Darwin Global Management as of June 30, 2024
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 9 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 28.6 | $246M | 4.6M | 53.78 | |
| Insmed Com Par $.01 (INSM) | 27.6 | $237M | 3.5M | 66.95 | |
| Vaxcyte (PCVX) | 19.1 | $164M | 2.1M | 78.77 | |
| Geron Corporation (GERN) | 12.4 | $106M | 24M | 4.44 | |
| Keros Therapeutics (KROS) | 8.0 | $69M | 1.5M | 45.07 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.7 | $14M | 325k | 43.88 | |
| Spyre Therapeutics Com New (SYRE) | 1.2 | $10M | 452k | 22.71 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $8.1M | 200k | 40.54 | |
| Elevation Oncology (ELEV) | 0.6 | $4.8M | 1.9M | 2.51 |
